cardiovascular disease
Conditions
Interventions
Sponsors
The second teaching hospital of Tianjin university of Traditonal Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Warfarin users; 2. For 18-65 years of age; 3. male or female; 4. to sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients within 3rd days after surgery and surgery in the near future, the brain, spinal cord and eye surgery - seekers; 2. Patients with dysfunction of blood coagulation disorders, bleeding tendency; 3. Patients with peptic ulcer; vitamin K deficiency with a variety of reasons; tissue and organ damage with bleeding; 4. Patients with severe liver and kidney diseases; patients with cerebral hemorrhage and cerebral aneurysms; patients with infective endocarditis; with severe hypertension and blood pressure could not be effectively controlled; those poor blood sugar control of diabetes; 5. Pregnant or lactating women; 6. Patients with allergies; 7. Patients those used in compound danshen drop pills within 3 days before entering the trial; 8. Patients whom the researchers consider not to be appropriate to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| coagulation function; | — |
Countries
China
Contacts
Public ContactHuang Yuhong
Outcome results
None listed